BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16885753)

  • 1. Water may cure patients with Meniere disease.
    Naganuma H; Kawahara K; Tokumasu K; Okamoto M
    Laryngoscope; 2006 Aug; 116(8):1455-60. PubMed ID: 16885753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic injections of dexamethasone for long-term control of vertigo.
    Barrs DM
    Laryngoscope; 2004 Nov; 114(11):1910-4. PubMed ID: 15510013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
    Li CS; Lai JT
    Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of endolymphatic mastoid shunt surgery in patients with intractable Ménière's disease.
    Yu MS; Lee KS; Chung JW
    Otolaryngol Head Neck Surg; 2009 Aug; 141(2):237-42. PubMed ID: 19643258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vestibular neurectomy vs. chemical labyrinthectomy in the treatment of disabling Menière's disease: a long-term comparative study.
    Schmerber S; Dumas G; Morel N; Chahine K; Karkas A
    Auris Nasus Larynx; 2009 Aug; 36(4):400-5. PubMed ID: 19026499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The medical management of fluctuant hearing loss.
    Shea JJ; Konishi S
    Laryngoscope; 1969 Apr; 79(4):714-26. PubMed ID: 5778872
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of low-level laser therapy in Ménière's disease: a pilot study of 10 patients.
    Teggi R; Bellini C; Fabiano B; Bussi M
    Photomed Laser Surg; 2008 Aug; 26(4):349-53. PubMed ID: 18665761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postural instability in Meniere's disease.
    Havia M; Kentala E; Pyykkö I
    J Vestib Res; 2004; 14(1):37-46. PubMed ID: 15156095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B; Ozgirgin N; Ozlüoğlu LN
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of initial electronystagmography findings in idiopathic sudden sensorineural hearing loss without vertigo.
    Junicho M; Fushiki H; Aso S; Watanabe Y
    Otol Neurotol; 2008 Oct; 29(7):905-9. PubMed ID: 18636036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome.
    Suryanarayanan R; Srinivasan VR; O'Sullivan G
    J Laryngol Otol; 2009 Jan; 123(1):45-9. PubMed ID: 18533050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meniett therapy may avoid vestibular neurectomy in disabling Meniere's disease.
    Barbara M; Monini S; Chiappini I; Filipo R
    Acta Otolaryngol; 2007 Nov; 127(11):1136-41. PubMed ID: 17851896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease.
    Colletti V; Carner M; Colletti L
    Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops.
    Kitahara T; Maekawa C; Kizawa K; Horii A; Doi K
    Otol Neurotol; 2009 Sep; 30(6):812-9. PubMed ID: 19638944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cochlear conductive hearing loss in patients with Meniere's disease.
    Yetişer S; Kertmen M
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):18-21. PubMed ID: 17483606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disability in patients with Menière's disease following the use of two different treatment modalities: betahistine and intratympanic gentamicin.
    Enrique-Gonzaleza A; Sánchez-Ferrándiz N; Pérez-Fernández N
    Rev Laryngol Otol Rhinol (Bord); 2008; 129(4-5):249-54. PubMed ID: 19408504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a single intratympanic gentamicin injection on Meniere's disease.
    Chung WH; Chung KW; Kim JH; Cho YS; Hong SH
    Acta Otolaryngol Suppl; 2007 Oct; (558):61-6. PubMed ID: 17882572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple semicircular canal occlusion for the treatment of Ménière's disease.
    Yin S; Chen Z; Yu D; Wu Y; Shi H; Zhou H; Wang J
    Acta Otolaryngol; 2008 Jul; 128(7):739-43. PubMed ID: 18568514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.